✦ LIBER ✦

PCV48 MEDICATION USE AND ASSOCIATED ANNUAL COSTS IN PATIENTS AT RISK OF ATHEROTHROMBOSIS: RESULTS FOR GERMANY, SPAIN AND THE UK FROM THE REDUCTION OF ATHEROTHROMBOSIS FOR CONTINUED HEALTH (REACH) REGISTRY

✍ Scribed by EM Mahoney; K Wang; B Bruggenjurgen; A Bakhai

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ethnic differences in the relationships

✍ Tzung-Dau Wang; Shinya Goto; Deepak L. Bhatt; Philippe Gabriel Steg; Juliana C.N 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 510 KB

Cardiovascular risk profile and outcome

✍ Iris Baumgartner; Alan T. Hirsch; Maria Teresa B. Abola; Patrice P. Cacoub; Don 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Cardiovascular risk factor control and o

✍ Patrice P. Cacoub; Maria Teresa B. Abola; Iris Baumgartner; Deepak L. Bhatt; Mar 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 258 KB

Ethnic Differences in Cardiovascular Ris

✍ Meadows, Telly A.; Bhatt, Deepak L.; Cannon, Christopher P.; Gersh, Bernard J.; 📂 Article 📅 2011 🏛 Mayo Clinic 🌐 English ⚖ 171 KB

PCV60 TWO-YEAR HOSPITALIZATION RATES AND

✍ EM Mahoney; Y Lei; K Wang; B Bruggenjurgen; F Mosse; KG Parhofer; U Zeymer; J Ro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

OPL074 Comparison of risk factors betwee

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 250 KB